Page last updated: 2024-10-29

isocarboxazid and Anoxia, Brain

isocarboxazid has been researched along with Anoxia, Brain in 1 studies

Isocarboxazid: An MAO inhibitor that is effective in the treatment of major depression, dysthymic disorder, and atypical depression. It also is useful in the treatment of panic disorder and the phobic disorders. (From AMA, Drug Evaluations Annual, 1994, p311)

Research Excerpts

ExcerptRelevanceReference
"The neurochemical basis of myoclonus responding to 5HT precursors and clonazepam is discussed."1.26Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam. ( Chadwick, D; Hallett, M; Harris, R; Jenner, P; Marsden, CD; Reynolds, EH, 1977)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chadwick, D1
Hallett, M1
Harris, R1
Jenner, P1
Reynolds, EH1
Marsden, CD1

Other Studies

1 other study available for isocarboxazid and Anoxia, Brain

ArticleYear
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
    Brain : a journal of neurology, 1977, Volume: 100, Issue:3

    Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Benzodiazepinones; Carbidopa; Child, Preschool; Clonaz

1977